Hematologic Toxicities in Colorectal Cancer Patients who Received FOLFOX4

Hematologic Toxicities in Colorectal Cancer Patients who Received FOLFOX4

Background: Over the past decade, survival from advanced colorectal cancer is increasing. Therefore patients have more exposure to chemotherapy and related toxicities. This study determines how hematologic toxicity patterns affect therapy and care. Methods: From April 2010 to March 2013, we enro...

Full description

Bibliographic Details
Main Authors: Mehdi Dehghani, Nematollah Hafezi, Reza Vojdani, Mani Ramzi, Mojtaba Karimi, Habib Nourani, Maryam Zakerinia, Zahra Bahador
Format: Article
Language:English
Published: Shiraz University of Medical Sciences 2015-07-01
Series:Middle East Journal of Cancer
Subjects:
Colorectal cancer
Chemotherapy
FOLFOX4
Granulocyte colony stimulating factor
Hematologic toxicities
Online Access:http://mejc.sums.ac.ir/index.php/mejc/article/view/237/217

Internet

http://mejc.sums.ac.ir/index.php/mejc/article/view/237/217

Similar Items